You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 10, 2025

Drug Price Trends for MAPAP


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for MAPAP

Average Pharmacy Cost for MAPAP

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
MAPAP 500 MG CAPSULE 00904-1987-60 0.03611 EACH 2025-01-22
MAPAP COLD FORMULA CAPLET 00904-5786-24 0.09273 EACH 2025-01-22
MAPAP 500 MG/15 ML LIQUID 00904-5847-09 0.01375 ML 2025-01-22
MAPAP 500 MG CAPSULE 00904-1987-60 0.03584 EACH 2024-12-18
MAPAP COLD FORMULA CAPLET 00904-5786-24 0.09413 EACH 2024-12-18
MAPAP 500 MG/15 ML LIQUID 00904-5847-09 0.01377 ML 2024-12-18
MAPAP 500 MG CAPSULE 00904-1987-60 0.03616 EACH 2024-11-20
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Acetaminophen (MAPAP)

Introduction to Acetaminophen (MAPAP)

Acetaminophen, commonly known by the brand name Tylenol or the generic term MAPAP (Maximum Strength Acetaminophen), is a widely used over-the-counter (OTC) and prescription medication for pain relief and fever reduction. Here’s a comprehensive analysis of the market and price projections for acetaminophen.

Global Market Size and Growth

The global acetaminophen market is substantial and growing steadily. As of 2022, the market was valued at USD 9.8 billion and is projected to expand at a Compound Annual Growth Rate (CAGR) of 4.2% to reach USD 15.2 billion by 2033[1].

Key Drivers of Demand

Several factors are driving the demand for acetaminophen:

  • Increasing Chronic Illnesses: The rise in chronic illnesses such as cancer and chronic obstructive pulmonary disease (COPD) is contributing to the increased demand for pain management medications, including acetaminophen[1].
  • Opioid Tolerance: The growing concern over opioid tolerance and addiction has led to a shift towards non-opioid pain relievers like acetaminophen. This trend is expected to continue, driving market growth[1].
  • Post-Operative Pain Management: Acetaminophen is widely used in post-operative pain management, further fueling its demand[1].

Market Segmentation

Route of Administration

The oral route of administration dominates the acetaminophen market, accounting for approximately 92.4% of the market share in 2022. This is due to the convenience and efficacy of oral formulations[1].

Distribution Channels

Retail pharmacies hold a significant market share, with around 42.6% of the pain management drugs market, including acetaminophen, being distributed through this channel. Online and hospital pharmacies also play important roles but to a lesser extent[3].

Competitive Landscape

The acetaminophen market is highly competitive, with several major pharmaceutical companies involved:

  • Key Players: Pfizer Inc., Sanofi, Janssen Pharmaceuticals, Bayer AG, GlaxoSmithKline plc, Bristol-Myers Squibb and Company, Teva Pharmaceutical Industries Ltd, Cardinal Health Inc., Perrigo Company, Novartis AG, Sun Pharmaceutical Industries Ltd, Abbott, Mallinckrodt Pharmaceuticals, and Procter & Gamble Company are some of the prominent players in the market[1].

Regulatory Environment

The development, approval, and marketing of acetaminophen are governed by stringent regulatory frameworks, particularly in regions like North America. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and Health Canada ensure high standards of safety and efficacy, which can impact market dynamics[3].

Price Projections and Trends

General Trends

Prescription drug prices, including those for acetaminophen, have been increasing faster than the rate of general inflation. This trend is expected to continue, with employers predicting an average increase of 8% in prescription drug costs in 2025[5].

Specific to Acetaminophen

While acetaminophen is generally more affordable than many other prescription drugs, its prices can still be affected by broader market trends. The introduction of extended-release formulations and other innovative delivery methods may influence pricing, offering better value to patients but potentially at a higher cost[4].

Impact of Extended-Release Formulations

Extended-release formulations of acetaminophen offer several advantages, including extended medication effectiveness, improved patient compliance, and smoother drug delivery. These benefits are expected to drive market growth, with the global paracetamol market projected to grow at a CAGR of 9.42% from 2024 to 2028 due to such innovations[4].

Regional Market Analysis

North America

The North American market for pain management drugs, including acetaminophen, is significant and growing. This region is expected to reach USD 42 billion by 2032, driven by factors such as a high incidence of chronic diseases, a growing elderly population, and advanced healthcare infrastructure[3].

Challenges and Opportunities

High Drug Prices

The increasing prices of prescription drugs, including acetaminophen, pose a challenge for both patients and healthcare systems. High prices can lead to increased cost sharing and higher premiums for health care coverage, as well as higher government spending on prescription drugs[2].

Innovation and R&D

Pharmaceutical companies are investing heavily in research and development to discover and develop novel pain management medications. Innovations such as abuse-deterrent formulations and new delivery technologies present opportunities for market growth and improved patient outcomes[3].

Key Takeaways

  • Growing Market: The global acetaminophen market is expected to grow at a CAGR of 4.2% from 2023 to 2033.
  • Key Drivers: Increasing chronic illnesses, opioid tolerance, and post-operative pain management are driving demand.
  • Competitive Landscape: The market is highly competitive with several major pharmaceutical companies involved.
  • Regulatory Environment: Stringent regulatory frameworks govern the market, ensuring safety and efficacy.
  • Price Trends: Prescription drug prices are increasing, with extended-release formulations potentially influencing pricing.
  • Regional Growth: North America is a significant market driven by chronic diseases and advanced healthcare infrastructure.

FAQs

Q: What is the current market size of the global acetaminophen market? A: The global acetaminophen market was valued at USD 9.8 billion in 2022[1].

Q: What is the projected growth rate of the acetaminophen market from 2023 to 2033? A: The market is expected to grow at a CAGR of 4.2% from 2023 to 2033[1].

Q: Which route of administration dominates the acetaminophen market? A: The oral route of administration dominates the market, accounting for approximately 92.4% of the market share in 2022[1].

Q: How are extended-release formulations impacting the acetaminophen market? A: Extended-release formulations are driving market growth by offering extended medication effectiveness, improved patient compliance, and smoother drug delivery[4].

Q: What are the main drivers of demand for acetaminophen? A: The main drivers include increasing chronic illnesses, opioid tolerance, and post-operative pain management[1].

Sources

  1. Future Market Insights - Acetaminophen Market Size, Share, Trends & Outlook - 2033
  2. AARP - AARP Report Finds Top 10 Prescription Drug Price Hikes
  3. Global Market Insights - Pain Management Drugs Market Share, Trends & Forecast, 2032
  4. PR Newswire - Paracetamol Market size is set to grow by USD 929.4 million from 2024-2028
  5. Managed Healthcare Executive - Employers Predict Drug Prices Will Increase in 2025, Survey Shows

More… ↓

⤷  Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.